Wednesday, 9 October 2013

are omega-3 ...dying out?



some new evidence on the non-efficacy of omega-3 pills against cardiovascular diseases (CVDs):




3.  AstraZeneca Pushing Fish Oil Drugs – About Medicine or Money?

"High cholesterol and its accompanying risk, heart disease, are serious matters. But throwing a new drug at the problem is not always the best answer. Particularly not when the driving interest behind a new drug seems to be improving market shares and securing drug patents, and omega-3 fatty acides can be obtained through other, less expensive and probably as effective means."

“Based on the totality of current evidence, the pendulum appears to be shifting away from omega-3 fatty acid supplementation providing significant cardiovascular event reduction,” according to Dr. Gregg Fonarow, a professor of cardiology at the University of California, Los Angeles. (Health Day

"During five years of follow-up, more than 1,400 people died from heart disease or had a heart attack or stroke, the researchers found. Among those taking omega-3 fatty acid supplements, 11.7 percent had one of these outcomes, compared to 11.9 percent of those taking a placebo."  [from here]


the conclusion...is this one:

why taking pills that do not work on CVDs?

something new is needed and I would be able to talk about that in few weeks in this conference

"International Conference on Natural Products Utilization , From Plants to Pharmacy Shelf , ICNPU 2013, 3-6 November 2013, Bansko, Bulgaria"
  
The title of my talk is:
 
"Exploiting Olive Pomace to produce sustainably aquacultured fish with enhanced cardioprotective properties"



p.s. watch this space :) 

 

No comments: